Subjective cognitive decline (SCD) is regarded as the first clinical manifestation in the
Alzheimer's disease (AD) continuum. Investigating populations with SCD is important for …

Abnormal glucose metabolism and hemodynamic changes in the brain are closely related to
cognitive function, providing complementary information from distinct biochemical and …

Background Subjective cognitive decline (SCD) appears in the preclinical stage of the
Alzheimer's disease continuum. In this stage, dynamic features are more sensitive than static …

Background Subjective cognitive decline (SCD) is a putative Alzheimer's disease (AD)
precursor without objective neuropsychological deficits. The hippocampus plays an …

Individuals with subjective cognitive decline (SCD) are more likely to develop into Alzheimer
disease (AD) in the future. Resting-state functional magnetic resonance imaging (rs-fMRI) …

Background: Voxel-based morphometry studies have not yielded consistent results among
patients with mild cognitive impairment (MCI) and subjective cognitive decline (SCD) …

Background: Individuals with subjective cognitive decline (SCD) are thought to be the
earliest along the cognitive continuum between healthy aging and Alzheimer's disease (AD) …

Background: Amyloid-accumulation was found to alter precuneus-based functional
connectivity (FC) in mild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia …

Subjective cognitive decline (SCD) is considered the first stage of Alzheimer's disease (AD).
Accurate diagnosis and the exploration of the pathological mechanism of SCD are extremely …

Single modality MRI data is not enough to depict and discern the cause of the underlying
brain pathology of Alzheimer's disease (AD). Most existing studies do not perform well with …